Moderna Inc MRNA Competitive Landscape Shifts Following HeadtoHead COVID Vaccine Trial Results and Peer Catalyst Updates SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading WRN Western meets Q4 2025 analyst EPS estimates registers modest share gains following earnings release